Published in Arch Otolaryngol Head Neck Surg on February 01, 2004
Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer. Br J Cancer (2008) 1.32
Squamous cell carcinoma of the head and neck in the elderly. Rep Pract Oncol Radiother (2012) 0.98
Treatment of older patients with head and neck cancer: a review. Oncologist (2013) 0.89
Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy. J Geriatr Oncol (2013) 0.85
Undesirable financial effects of head and neck cancer radiotherapy during the initial treatment period. Int J Circumpolar Health (2015) 0.75
Mortality in tongue cancer patients treated by curative surgery: a retrospective cohort study from CGRD. PeerJ (2016) 0.75
Tumor site and disease stage as predictors of quality of life in head and neck cancer: a prospective study on patients treated with surgery or combined therapy with surgery and radiotherapy or radiochemotherapy. Eur Arch Otorhinolaryngol (2015) 0.75
Supportive care in patients with advanced non-small-cell lung cancer. Br J Cancer (2003) 1.04
Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome. Oral Oncol (2005) 1.03
Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas. Clin Cancer Res (2007) 1.02
Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas. Head Neck (2007) 0.96
Head and neck squamous cell carcinoma: role of the human papillomavirus in tumour progression. New Microbiol (2006) 0.92
Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design. J Clin Oncol (2002) 0.92
beta-carotene supplementation in patients radically treated for stage I-II head and neck cancer: results of a randomized trial. Oncol Rep (2003) 0.91
Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma. Cancer Chemother Pharmacol (2010) 0.90
Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population. Radiother Oncol (2009) 0.89
Docetaxel and vinorelbine: an effective regimen in recurrent squamous cell esophageal carcinoma. Med Oncol (2003) 0.88
Radiofrequency inferior turbinate reduction: long-term olfactory and functional outcomes. Otolaryngol Head Neck Surg (2011) 0.87
The platysma myocutaneous flap (PMF) for head and neck reconstruction: a retrospective and multicentric analysis of 91 T1-T2 patients. J Craniomaxillofac Surg (2012) 0.87
Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer. World J Surg (2004) 0.87
The monitoring role of otoacoustic emissions and oxidative stress markers in the protective effects of antioxidant administration in noise-exposed subjects: a pilot study. Med Sci Monit (2009) 0.87
Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. Head Neck (2009) 0.86
Overexpression of p27BBP in head and neck carcinomas and their lymph node metastases. Head Neck (2004) 0.86
Clinical and biological prognostic factors in 179 cases with sinonasal carcinoma treated in the Italian Piedmont region. Oncology (2009) 0.85
Improved survival with perilymphatic interleukin 2 in patients with resectable squamous cell carcinoma of the oral cavity and oropharynx. Cancer (2002) 0.85
13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group. Oncol Rep (2004) 0.84
Functional and psychological evaluation after flap reconstruction plus radiotherapy in oral cancer. Head Neck (2011) 0.84
Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer. New Microbiol (2013) 0.83
Playing a brass instrument after total laryngectomy: a case report. Head Neck (2009) 0.82
Radiofrequency volume turbinate reduction versus partial turbinectomy: clinical and histological features. Am J Rhinol Allergy (2012) 0.80
Histamine inhalation challenge in recurrent uvula angioedema. J Allergy Clin Immunol (2003) 0.80
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study. Breast Cancer Res Treat (2011) 0.80
Radiofrequency inferior turbinate reduction: an evaluation of olfactory and respiratory function. Otolaryngol Head Neck Surg (2010) 0.80
Pharmacokinetic study of oxaliplatin iv chronomodulated infusion combined with 5-fluorouracil iv continuous infusion in the treatment of advanced colorectal cancer. Farmaco (2003) 0.79
Docetaxel, carboplatin and concomitant radiotherapy for unresectable squamous cell carcinoma of the head and neck: pharmacokinetic and clinical data of a phase I-II study. Am J Clin Oncol (2004) 0.79
Docetaxel and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results. Am J Clin Oncol (2003) 0.79
Constitutive expression of interleukin-18 in head and neck squamous carcinoma cells. Head Neck (2004) 0.79
Palatine tonsils in smoker and non-smoker patients: a pilot clinicopathological and ultrastructural study. J Oral Pathol Med (2005) 0.78
Clinical data and pharmacokinetics of a docetaxel-vinorelbine combination in anthracycline resistant/ relapsed metastatic breast cancer. Acta Oncol (2003) 0.78
Carboplatin plus taxol is an effective third-line regimen in recurrent undifferentiated nasopharyngeal carcinoma. Tumori (2002) 0.78
Combined endovascular and surgical treatment of carotid body tumor in a patient with thoracic situs solitus. Head Neck (2008) 0.77
Paclitaxel and pegylated liposomal doxorubicin in recurrent head and neck cancer: clinical and unexpected pharmacokinetic interactions. Anticancer Res (2008) 0.77
Benign paroxysmal positional vertigo and orthostatic hypotension. Clin Auton Res (2009) 0.77
Cisplatin+Vinorelbine Treatment of Recurrent or Metastatic Salivary Gland Malignancies (RMSGM): A Final Report on 60 Cases. Am J Clin Oncol (2017) 0.76
Gemcitabine and oxaliplatin in patients with pancreatic adenocarcinoma: clinical and pharmacokinetic data. Pancreas (2006) 0.76
Gemcitabine and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results. Anticancer Res (2003) 0.76
The importance of preoperative swallowing therapy in subtotal laryngectomies. Otolaryngol Head Neck Surg (2009) 0.75
[NHIL epidemiology in Italy. 20 years from DLgs 277/91: review and expectations]. G Ital Med Lav Ergon (2011) 0.75
Gemcitabine and oxaliplatin in patients with metastatic breast cancer resistant to or pretreated with both anthracyclines and taxanes: clinical and pharmacokinetic data. Am J Clin Oncol (2006) 0.75
A study of neck and shoulder morbidity following neck dissection: The benefits of cervical plexus preservation. Ear Nose Throat J (2015) 0.75
The prognostic value of the otoacoustic emission test in low frequency sudden hearing loss. Eur Arch Otorhinolaryngol (2004) 0.75
Orthostatic hypotension and psychiatric comorbidities in patients with dizziness. Am J Otolaryngol (2011) 0.75
[Crenotherapy and upper airways diseases. Consensus Conference]. Acta Otorhinolaryngol Ital (2006) 0.75
Plexiform schwannoma of the posterior pharyngeal wall in a patient with neurofibromatosis 2. Ear Nose Throat J (2015) 0.75
Mucous membrane plasmacytosis of the nose in a patient affected by B-cell chronic lymphocytic leukemia. Eur Arch Otorhinolaryngol (2008) 0.75